Gene · 3226
HOXC10: homeobox C10
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HOXC10: homeobox C10. Genes, record 3226. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3226
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NYD6 | Homeobox protein Hox-C10 | 342 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents44
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4805378 A1 | 2026-09-16 | 115 | Q9NYD6 | Espacenet |
| JP 2026523341 A | 2026-07-14 | 574 | Q9NYD6 | Espacenet |
| EP 4771137 A1 | 2026-07-08 | 112 | Q9NYD6 | Espacenet |
| EP 4771157 A1 | 2026-07-08 | 112 | Q9NYD6 | Espacenet |
| US 12649003 B2 | 2026-06-09 | 574 | Q9NYD6 | Espacenet |
| JP 2026510339 A | 2026-04-02 | 112 | Q9NYD6 | Espacenet |
| EP 4713451 A2 | 2026-03-25 | 112 | Q9NYD6 | Espacenet |
| EP 4713452 A2 | 2026-03-25 | 112 | Q9NYD6 | Espacenet |
| US 12558437 B2 | 2026-02-24 | 574 | Q9NYD6 | Espacenet |
| EP 4677082 A2 | 2026-01-14 | 112 | Q9NYD6 | Espacenet |
1 to 10 of 44
See all 44 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,366
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HOXC10 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| R01AG069901 | ADMINISTRATIVE SUPPLEMENT - TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease | 4 | 2025 |
| P01AI106695 | Protective immunity following dengue virus natural infections and vaccination | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 3 | 2025 |
| R01AG081322 | Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease | 3 | 2025 |
| R01HL105826 | Fast myosin binding protein-C and cardiac contractility in heart failure | 3 | 2025 |
1 to 10 of 1,366Source NIH's project files
See all 1,366 nih grantsPapers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fibroblast Heterogeneity Links Inflammatory Microenvironments to Tissue Remodeling in Chronic Rhinosinusitis. | Int Arch Allergy Immunol | 2026 | 42809484 | PubTator, text mining | PubMed |
| Acoustic cell patterning reveals geometry- and substrate-dependent vasculogenesis and human embryo model development. | Nat Commun | 2026 | 42764291 | PubTator, text mining | PubMed |
| Ultrasensitive de novo Protein Sandwich Lateral flow Fluorescence Assay for Cortisol in Saliva and Serum using Quantum dots and Europium Nanoparticles. | J Fluoresc | 2026 | 42364004 | PubTator, text mining | PubMed |
| Aggregation behavior of sodium caprate under different pH, concentration, and intestinal fluid conditions: a coarse-grained molecular dynamics study comparing Martini 2 and Martini 3. | Phys Chem Chem Phys | 2026 | 42171071 | PubTator, text mining | PubMed |
Statement of Retraction: MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway. | Bioengineered | 2026 | 42165428 | PubTator, text mining | PubMed |
| The astragaloside-brucea javanica oil nanoemulsion inhibiting the progression of oral squamous cell carcinoma through CDK1- HOXC10-MTFR2 pathway. | Bioorg Chem | 2026 | 42134202 | PubTator, text mining | PubMed |
| Hybrid Supercharged Antibodies: A Rational Approach to Boost Immunoassay Sensitivity via Controlled Nanoparticle Adsorption. | Langmuir | 2026 | 41932683 | PubTator, text mining | PubMed |
| Generation of Novel Natural Products by Disrupting Azaphilone Synthesis in Penicillum sclerotiorum E23Y-1A. | Mar Drugs | 2026 | 41892954 | PubTator, text mining | PubMed |
| Axial Identity of Spinal Cord Neural Progenitor Cell Grafts Is Dispensable for Regeneration and Functional Recovery After Spinal Cord Injury. | Cells | 2026 | 41892288 | PubTator, text mining | PubMed |
| Targeting SPP1 +TAMs associated with liver metastasis reverses immunosuppression and synergizes with immunotherapy in colorectal cancer. | J Immunother Cancer | 2026 | 41881501 | PubTator, text mining | PubMed |
1 to 10 of 2,594
See all 2,594 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3226
GET https://conductscience.org/api/genes/v1/3226/patents?page=2